Aosaikang Pharmaceutical
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A pharmaceutical company with a core generics business, now developing innovative small molecule drugs across several disease areas.
OncologyMetabolic DiseasesAnti-infectives
Technology Platform
Core capabilities in small molecule synthesis, formulation, and manufacturing, with growing investment in novel drug discovery.
Opportunities
Leveraging its commercial infrastructure to successfully launch innovative drugs in the large Chinese market.
Risk Factors
The innovative pipeline may lack sufficient differentiation to succeed commercially against more advanced competitors.
Competitive Landscape
Faces dual competition: in the crowded, price-sensitive generics market and in the innovative drug space against more focused R&D companies.